Rafael Maldonado López-rekin lankidetzan egindako argitalpenak (11)

1998

  1. Antinociception produced by the peptidase inhibitor, RB 101, in rats with adrenal medullary transplant into the spinal cord

    European Journal of Pharmacology, Vol. 356, Núm. 2-3, pp. 139-148

  2. Involvement of δ-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model

    European Journal of Pharmacology, Vol. 354, Núm. 1, pp. 1-7

1995

  1. Implication of endogenous opioid system in the learned helplessness model of depression

    Pharmacology, Biochemistry and Behavior, Vol. 52, Núm. 1, pp. 145-152

  2. Study of the mechanisms involved in behavioral changes induced by flunitrazepam in morphine withdrawal

    Progress in Neuropsychopharmacology and Biological Psychiatry, Vol. 19, Núm. 5, pp. 973-991

1994

  1. Participation of opioid and monoaminergic mechanisms on the antinociceptive effect induced by tricyclic antidepressants in two behavioural pain tests in mice

    Progress in Neuropsychopharmacology and Biological Psychiatry, Vol. 18, Núm. 6, pp. 1073-1092

1993

  1. Effect of mixed (RB 38A) and selective (RB 38B) inhibitors of enkephalin degrading enzymes on a model of depression in the rat

    Biological Psychiatry, Vol. 34, Núm. 1-2, pp. 100-107

1992

  1. Changes in benzodiazepine-receptor activity modify morphine withdrawal syndrome in mice

    Drug and Alcohol Dependence, Vol. 30, Núm. 3, pp. 293-300

1991

  1. Influence of different benzodiazepines on the experimental morphine abstinence syndrome

    Psychopharmacology, Vol. 105, Núm. 2, pp. 197-203

1990

  1. Modification of the morphine withdrawal syndrome in mice by benzodiazepine-receptor ligands

    European Journal of Pharmacology

  2. RB 38 B, a selective neutral endopeptidase inhibitor, induced reversal of escape deficits caused by inescapable shocks pretreatment in rats

    European Journal of Pharmacology

1988

  1. Comparative study in mice of flunitrazepam vs. diazepam on morphine withdrawal syndrome

    Progress in Neuropsychopharmacology and Biological Psychiatry, Vol. 12, Núm. 6, pp. 927-933